Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 20/1/2018
SIETES contiene 92186 citas

 
 
 1 a 20 de 47 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Montané E, Arellano AL, Sanz Y, Roca J, Farré M. Drug-related deaths in hospital inpatients: a retrospective cohort study. Br J Clin Pharmacol 2017;84:1. [Ref.ID 102184]
2. Cita con resumen
Raccah BH, Perlman AI, Danenberg HD, Pollak A, Muszkat M, Matok I. Major bleeding and hemorrhagic stroke with direct oral anticoagulants in patients with renal failure. Chest 2016;149:1516-24. [Ref.ID 101481]
3. Cita con resumen
Southworth MR, Reichman ME, Unger EF. Dabigatran and postmarketing reports of bleeding. N Engl J Med 2013;368:1. [Ref.ID 95100]
4. Cita con resumen
Bosch M, Llop R, Lalueza P, Villar MM. Nuevos anticoagulantes orales para la prevención del ictus en pacientes con fibrilación auricular no valvular. Med Clin (Barc) 2013;140:229-31. [Ref.ID 95047]
5.
González López E, González-Ríos P, Otero-Puime A, Ramos Quirós E. Calidad de vida de los pacientes tratados con dicumarínicos. Med Clin (Barc) 2012;139:696-7. [Ref.ID 94290]
7.Enlace a cita original Cita con resumen
Miller CS, Grandi SM, Shimony A, Filion KB, Eisenberg MJ. Meta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation. Am J Cardiol 2012;110:453-60. [Ref.ID 92622]
8. Cita con resumen
Warlé-van Herwaarden MF, Kramers C, Sturkenboom MC, van den Bemt PMLA. Targeting outpatient drug safety: recommendations of the Dutch HARM-Wrestling Task Force. Drug Saf 2012;35:245-59. [Ref.ID 92433]
9. Cita con resumen
Anónimo. Prothrombin complex concentrates to reverse warfarin-related bleeding. Med Lett Drugs Ther 2011;53:78-9. [Ref.ID 91712]
10.Enlace a cita original
Broos N, van Puijenbroek EP. Interaction between topical miconazole and coumarins. Eur J Clin Pharmacol 2010;66:1171-2. [Ref.ID 89588]
11.
Anónimo. Self-monitoring for patients on warfarin?. Med Clin (Barc) 2009;47:98-101. [Ref.ID 86718]
12. Cita con resumen
Baxter K, Sharp JM. Adverse drug interactions. Adv Drug React Bull 2008;248:951-4. [Ref.ID 82877]
13.
Shalekamp T, van Geest-Daalderop JHH, Kramer MHH, van Holten-Verzantvoort ATM, de Boer A. Coumarin anticoagulants and co-trimoxazole: avoid the combination rather than manage the interaction. Eur J Clin Pharmacol 2007;63:335-43. [Ref.ID 79817]
14.
Jönsson AK, Spigset O, Jacobsson I, Hägg S. Cerebral haemorrhage induced by warfarin - the influence of drug-drug interactions. Pharmacoepidemiol Drug Saf 2007;16:309-15. [Ref.ID 79574]
15. Cita con resumen
Paterson JM, Mamdani M, Juurlink DN, Naglie G, Laupacis A, Stukel TA, Institute for Clinical Evaluative Sciences. Clinical consequences of generic warfarin substitution: an ecological study. JAMA 2006;296:1969-70. [Ref.ID 78449]
16.
Brophy DF, Dougherty JA, Garrelts JC, Parish RC, Rivey MP, Stumpf JL, Taylor CT, Mathis AS. Venous thromboembolism prevention in acutely III nonsurgical patients. Ann Pharmacother 2005;39:1318-24. [Ref.ID 74460]
17. Cita con resumen
Anónimo. Interacciones del acenocumarol con importancia clínica. Boletín Terapéutico Andaluz 2004;20:1-4. [Ref.ID 70099]
18. Cita con resumen
Mahé I, Caulin C, Bergmann J-F. Does paracetamol potentiate the effects of oral anticoagulants?: A literature review. Drug Saf 2004;27:325-33. [Ref.ID 69884]
19.Tiene citas relacionadas
Torn M, van der Meer FJM, Rosendaal F R. Lowering the intensity of oral anticoagulant therapy. Effects on the risk of hemorrhage and thromboembolism. Arch Intern Med 2004;164:668-73. [Ref.ID 69623]
20.Tiene citas relacionadas
O'Donnell M. Establishing an optimal therapeutic range for coumarins. Filling in the gaps. Arch Intern Med 2004;164:588-90. [Ref.ID 69618]
Seleccionar todas
 
 1 a 20 de 47 siguiente >>